Wilmot Cancer Institute
- Interventional Clinical Trials at Wilmot continued to grow, particularly for prevention studies including screenings and smoking cessation tools.
- Philanthropic support has seeded several promising pilot grants that have potential to transform treatment options for cancer patients; many of these grants are eligible to apply for additional funding through foundations and federal agencies, which further amplifies the impact our donors have.
- Annual funds supported Wilmot’s recent recruitment of new faculty with a bold vision for the future, including Anna Weiss, MD, the new director of the Breast Cancer Service Line, Lauren Ghazel, PhD, FNP-BC, an associate member of the Cancer Prevention and Control program, and Marlies P. Rossmann, MD, PhD, an assistant professor in the Department of Biomedical Genetics.
Bullet points highlight impact made in 2022-23